Brazil to Launch AIDS Vaccine Human Trials in April
March 15, 2001
Researchers at the Federal University of Rio de Janeiro in Brazil, are planning to launch human trials of AIDS vaccines on 40 volunteers next month. The Brazilian team expects to have preliminary results by year-end for two vaccines, Aventis' Alvac and VaxGen's AIDSvax. A component of a vaccine development program coordinated by the U.S. National Institutes of Health and the HIV Network for Prevention Trials, the Brazilian results will help determine whether the trials should continue to Phase III. The trials will involve HIV-negative volunteers between the ages of 18 and 60 who are not injection drug users and have only had one sexual partner within the past six months.Adapted from:
Other CDC News for March 15, 2001
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.